Exploiting Catalytic Promiscuity for Biocatalysis:Carbon-Carbon Bond Formation by a Proline-Based Tautomerase by Miao, Yufeng
  
 University of Groningen
Exploiting Catalytic Promiscuity for Biocatalysis
Miao, Yufeng
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2015
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Miao, Y. (2015). Exploiting Catalytic Promiscuity for Biocatalysis: Carbon-Carbon Bond Formation by a
Proline-Based Tautomerase. [Groningen]: University of Groningen.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
3
Edzard M. Geertsema†, Yufeng Miao†, Pieter G. Tepper, Pim 
de Haan, Ellen Zandvoort, and Gerrit J. Poelarends
Published in Chem. Eur. J.  2013, 19, 14407-14410.
† These authors contributed equally to this work.
Biocatalytic Michael-type Additions 
of Acetaldehyde to Nitroolefins 




























The enzyme 4-OT promiscuously catalyzes the Michael-type addition of acetaldehyde to 
a collection of aromatic and aliphatic nitroolefins with high stereoselectivity producing 






















γ-Nitroaldehydes are versatile and practical precursors for chiral γ-aminobutyric acids 
(GABAs). In particular, prominent GABA analogues such as marketed pharmaceuticals 
phenibut[1] (GABAB receptor agonist, anxiolytic), pregabalin[2] (anticonvulsant), baclofen[3] 
(GABAB receptor agonist, anti-alcoholism), and rolipram[4] (type IV phosphodiesterase 
inhibitor, antidepressant) can be readily obtained from diverse chiral γ-nitroaldehydes by 
two, well-precedented, chemical synthesis steps.[5] One of the most important strategies 
to construct γ-nitroaldehydes is the Michael-type addition of unmodified aldehydes to 
nitroolefines.[6] Following this approach, construction of the appropriate γ-nitroaldehyde 
precursors for above-mentioned, pharmaceutically active GABA analogues would require 
the Michael-type addition of acetaldehyde to various nitroolefin acceptors (Scheme 1). The 
Michael-type addition of unmodified aldehydes to nitroolefines has recently become viable 
by the development of proline- and peptide-based organocatalysts.[7,8] However, examples 
including acetaldehyde as donor are scarce since acetaldehyde is a relatively reactive and 
difficult to tame chemical and 10-20 mol% of organocatalyst is typically applied.[9] Alternative 
procedures for the asymmetric synthesis of γ-nitroaldehydes from acetaldehyde and 
nitroolefins are therefore of great interest. Although a few examples of enzyme-catalyzed 
carbon-carbon bond-forming Michael-type additions are known, these do not involve 
acetaldehyde as donor and mainly exhibit low stereoselectivities. [10] 
Results and discussion
We here report that the enzyme 4-oxalocrotonate tautomerase (4-OT),[11] which carries 
a nucleophilic amino-terminal proline residue (Pro1), promiscuously catalyzes the 
asymmetric Michael-type addition of acetaldehyde to various aromatic and aliphatic 
nitroolefins yielding chiral γ-nitroaldehydes (Scheme 1) with high stereoselectivities. In 

























(acetaldehyde up to octanal) to trans-nitrostyrene,[12,13] this is the first example of enzyme-
catalyzed carbon-carbon bond-forming Michael-type additions that includes a range 
of linear aldehyde donors and a series of aromatic and aliphatic nitroolefin acceptors.[14] 
Furthermore, we found that catalytic activity of 4-OT is preserved in aqueous solvent 
systems containing up to 50% (v/v) of DMSO as co-solvent. The ‘Michaelase’ activity of 
4-OT and preservation of this activity in the presence of 50% (v/v) of an organic co-solvent 
are two important steps toward our aim of developing versatile and robust proline-based 
biocatalysts for carbon-carbon bond-forming Michael-type addition reactions. 
The 4-OT-catalyzed Michael-type addition with donor acetaldehyde 1 was explored with 
a series of nitroolefin acceptors (2a-f) in separate analytical scale experiments (Scheme 1). 
Nitroolefins 2a-f (0.7-3.0 mM)[15] were incubated with acetaldehyde 1 (25-150 mM)[16] and 
4-OT (32-150 µM)[16] in NaH2PO4 buffer (20 mM, pH 5.5) and a co-solvent. A co-solvent 
was required to achieve sufficient solubility of nitroolefins 2a-f in an aqueous solvent 
system. Apart from enhancing solubility of 2a-f, the co-solvent should be water-miscible, 
should not impede catalytic activity of 4-OT, and should not chemically react with any of 
the substrates (1 and 2a-f). Screening the activity of 4-OT in 20 mM NaH2PO4 buffer mixed 
with various amounts (5.0 to 72.5% v/v) of EtOH, DMSO, dioxane, THF, MeCN, and DMF 
revealed that EtOH (up to 10% v/v) and DMSO (up to 50% v/v) are suitable co-solvents that 
meet all above-mentioned criteria.[17]
The analytical scale reactions were followed by monitoring the change of absorbance 
at λmax of 2a-f by UV-spectroscopy.[18] During all reactions, decrease of the absorbance at 
λmax,2a-f was observed in course of time (20-120 min)[17] indicating almost complete depletion 
of nitroolefins 2a-f (Figures S1-S6 in the Supporting Information). Identical experiments 
with 4-OT and 2a-f, respectively, but in the absence of acetaldehyde 1 showed negligible 
decreases of absorbances at λmax,2a-f (except for compound 2c, vide infra) demonstrating that 
acetaldehyde 1 is involved in the 4-OT-catalyzed conversions of 2a-f (Figures S1-S6 in the 
Supporting Information). These experiments also confirmed that EtOH and DMSO solely 
act as co-solvents and not as reagents. Three types of additional control experiments were 
executed to confirm that the enzyme 4-OT and its catalytic Pro1 residue are responsible for 
conversions of 2a-f and 1 (Figures S1-S6 in the Supporting Information). First, incubation 
of 1 with nitroolefins 2a-f, respectively, but in the absence of 4-OT did not result in any 
significant decreases of absorbances at λmax,2a-f indicating that 4-OT is responsible for the 
catalytic activities. Second, experiments with 1 and 2a-f, respectively, in the presence of 
the P1A mutant of 4-OT showed no decreases of absorbances at λmax,2a-f implying that the 
Pro1 residue is crucial for the catalytic activities of 4-OT. Third, 1 and 2a were incubated 
with synthetic 4-OT[19] and the rate of decrease of absorbance at λmax,2a was identical to that 
observed with recombinant 4-OT. Although highly purified recombinant 4-OT was used in 
the analytical assays, this finding eliminated the possibility that any contaminating proteins 
from the expression strain may be responsible for catalysis.
Preparative scale experiments were performed to allow unambiguous product 





















of 1 with 2a-f give Michael-type addition adducts 3a-f (Table 1). Nitroolefin (2a-f: 2-5 
mM),[17] acetaldehyde (1, 50-150 mM),[16] and 4-OT (1.5-5.3 mol%)[16] were incubated in 
the appropriate solvent system (Table 1) and reactions were followed by UV spectroscopy. 
After disappearance of the absorbance at λmax of 2a-f, standard work-up and purification 
procedures were carried out which afforded γ-nitroaldehydes 3a-f as confirmed by 1H NMR 
spectroscopy. Yields between 49 and 74% were achieved for 3a-e while 3f was obtained 
in 26% yield. Products 3a-c,e are useful precursors for important GABA analogues since 
3a-b can be converted into rolipram,[5c,20] 3c into pregabalin,[5b] and 3e into baclofen[5a,b,d-f] 
in two or three chemical synthesis steps, respectively. Furthermore, obtaining products 
3a-f shows that 4-OT accepts aromatic as well as aliphatic nitroolefins as substrates for 
Michael-type addition reactions. The enantiomeric excesses (ee) of 3a-f were determined 
by GC or HPLC with chiral stationary phases. Excellent ee values between 95 and 98% 
were established for 3a, 3c, and 3d meaning that the enzyme 4-OT is highly stereoselective 
during the catalytic process. Obtained ee values of 3b,e,f range from 69 to 81%. The absolute 
configurations of the major enantiomers of 3a-f, respectively, were determined by HPLC 
and/or optical rotation.[17] Comparison with literature data revealed that the chiral centers 
of the major enantiomers of 3a-g, respectively, all have the identical geometry as depicted in 
Table 1. This means that the stereocontrol of 4-OT in the catalytic process of acetaldehyde 
addition to nitroolefins 3a-g is consistent regardless of the R-substituent (Scheme 1) at the 
nitroolefin. The major enantiomers of 3a,b,d-g have an (S)-configuration while 3c has an 
(R)-configuration. The deviant configuration of 3c is due to different prioritization of the 
substituents at the chiral center as compared to 3a,b,d-g. The amounts of applied 4-OT 
(1.5-3.7 mol%) were adjusted such that conversions of 2a,b,d-f were all completed within 
2.5 h. Conversion of aliphatic substrate 2c was effected within 25 min due to the presence of 
5.3 mol% of 4-OT. This amount of 4-OT was required to outcompete non-enzymatic water 
addition to 2c (giving racemic product 4-methyl-1-nitropentan-2-ol). Indeed, the amount 
of water addition product, 4-methyl-1-nitropentan-2-ol, went down from 4 to <2 mol% 
(compared to 3c) when 5.3 mol% of 4-OT was used instead of 2.6 mol% as determined 
by GC and 1H NMR spectroscopy. In contrast to 2c, non-enzymatic water addition to 
substrates 2a,b,d-f was not observed under the conditions used.
All preparative scale experiments of the 4-OT-catalyzed acetaldehyde addition to 
nitroolefins 2a-f were repeated under identical conditions but in the absence of 4-OT. In all 
cases no γ-nitroaldehyde product was observed (as confirmed by 1H NMR spectroscopy) 
demonstrating that formation of 3a-f is solely the result of 4-OT-catalyzed Michael-type 
additions and not of non-enzymatic addition of 1 to 2a-f. In case of 2c, non-enzymatic 
water addition resulted in formation of 4-methyl-1-nitropentan-2-ol as confirmed by 1H 





















Tabl e  1 .  Preparative scale 4-OT-catalyzed Michael-type addition reactions of acetaldehyde 1 (50-150 




















3 a 2.5 64 96 (S) 3.7 DMSO 40%
2 2 b 3 b 2.0 49 74 (S) 1.8 EtOH 10%
3 2 c 3 c 0.4 74 98 (R) 5.3 DMSO 5%
4 2 d 3 d 2.0 64 95 (S) 3.0 DMSO 40%
5 2 e 3 e 2.5 51 69 (S) 2.8 DMSO 45%
6 2 f 3 f 2.5 26 81 (S) 1.5 DMSO 40%
7[e] 2 g 3 g 2.0 70 81 (S) 1.4 EtOH 10%
[a] Isolated yields; [b] Determined by GC or HPLC with chiral stationary phase;[17] [c] determined with HPLC 






















Summarizing, this work presents a biocatalytic methodology for asymmetric Michael-type 
additions of acetaldehyde to a collection of aliphatic and aromatic nitroolefin acceptors. The 
Michael-type additions are promiscuously catalyzed by the enzyme 4-OT and yield chiral 
γ-nitroaldehydes which are valuable precursors for GABA analogues. Yields up to 74% and 
ee values up to 98% were established demonstrating that 4-OT exerts high stereoselectivity 
during the catalytic process. Control experiments revealed that the ‘Michaelase’ activity 
takes place in the active site of 4-OT. The catalytic activity of 4-OT is preserved in aqueous 
solvent systems containing up to 50% DMSO (v/v). This finding implies that the substrate 
scope of our biocatalytic methodology is not limited to water-soluble chemicals and allows 
utilization of poorly water-soluble nitroolefins as substrates. The employed amounts of 
catalyst of 1.4‒5.3 mol% in our methodology for Michael-type addition of acetaldehyde to 
nitroolefins are lower, and reactions times of ≤ 2.5 h are generally shorter, than in the scarce 
conventional organocatalytic methodologies for identical type of reactions.[9,17] Despite a 
relatively low molecular weight considering enzymes, the molecular mass of 4-OT is still 
considerably higher than those of organocatalysts[9] that are able to catalyze acetaldehyde 
addition to nitroolefins. Bearing this in mind, an alternative for defining catalyst efficiency 
on basis of the applied mol% of catalyst and reaction time is to assess catalyst efficiency 
by the weight amount of product (in terms of milligrams) that is produced per weight 
amount of used catalyst per unit of reaction time (mgproduct mgcatalyst‒1 h‒1). Applying the 
latter definition, 4-OT and the most potent organocatalyst[9e], to the best of our knowledge, 
are equally efficient in catalyzing the Michael-type addition of acetaldehyde (1) to 
nitrostyrene (2g).[9,17,21] This observation in combination with the broad substrate scope of 
our new enzyme-based methodology to prepare precursors of GABA analogues with high 
stereoselectivities inspired us to currently run protein engineering studies with the aim to 
enhance the unnatural ‘Michaelase’ activities of 4-OT. If successful, newly designed enzyme 
variants can also be tested in a whole cell system based on recombinantly expressed 4-OT, 
which appears to be an effective biocatalyst for the asymmetric Michael-type addition of 
acetaldehyde to a few selected aromatic β-nitrostyrenes.[22]
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2. Expression and purification of proteins
3. Nitroolefins 2a-f
4. Catalytic activity assay with 4-OT in water/co-solvent solvent systems
5. Analytical scale 4-OT-catalyzed Michael-type addition reactions
6. Preparative scale reactions, characterization, and enantiomeric excess determination of 3a-f
7. Synthesis of racemic 3a-f for enantiomeric excess determinations
8. Derivatization of 3a and 3b for enantiomeric excess determinations
9. HPLC and GC chromatograms of enantiomeric excess determinations
10. 1H NMR spectra of enzymatically obtained 3a-f and derivatized 3b
11.  Proposed reaction mechanism of 4-OT-catalyzed Michael-type addition of acetaldehyde 1 
to nitroolefins 2a-g
12. Absolute configuration determination of major enantiomers of enzymatically obtained 3a-g
1. General information 
Materials
All chemicals were purchased from Sigma-Aldrich Chemical Co. (St. Louis, MO) unless 
stated otherwise. The sources for the buffers, solvents, and components of Luria-Bertani (LB) 
media are reported elsewhere.[1] High purity synthetic 4-OT was obtained from GenScript 
USA Inc. (Piscataway, NY) and folded into the active homohexamer as described before.[2] 
General methods
Techniques for transformation and other standard molecular biology manipulations were 
based on methods described elsewhere.[3] Proteins were analyzed by polyacrylamide gel 
electrophoresis (PAGE) using sodium dodecyl sulfate (SDS) gels containing polyacrylamide 
(10%). The gels were stained with Coomassie Brilliant Blue. Protein concentrations were 
determined using the method of Waddell.[4] Enzymatic assays were monitored using a 
V-660 spectrophotometer purchased from Jasco (IJsselstein, The Netherlands). Evaporation 
of water/DMSO mixtures was performed with an acid-resistant CentriVap vacuum 
concentrator (Labconco, 78100 series) which was connected to a cold trap and a vacuum 
pump. NMR spectra were recorded on a Varian Inova 500 (500 MHz) or a Bruker DRX-500 





















(δ scale) and are referenced to CHCl3 (δ = 7.26). Reverse and normal phase HPLC was 
carried out using an in-house analytical HPLC equipped with a Shimadzu LC-10 AT pump 
and a Shimadzu SPD-M10A diode array detector using a Daicel Chiralpak AD-RH (reverse 
phase) or Chiralpak IB column (normal phase, Chiral Technologies Europe, Illkirch Cedex, 
France). The HPLC chromatographic data were analyzed by data processing software (LC 
Solutions) obtained from Shimadzu. Gas chromatography was carried out with a HP 5890 
series II gas chromatograph (HP chiral 20% Permethylated beta-cyclodextrin column). 
Optical rotations were measured in CHCl3 on a Schmidt + Haensch polarimeter (Polartronic 
MH8) with a 10 cm cell (c given in g/100 mL).
2. Expression and purification of proteins
The construction of the expression vectors and the purification procedure for wild type 4-OT and 
the P1A mutant were reported previously.[5] Wild type 4-OT enzyme and the P1A mutant were 
produced in E. coli BL21(DE3) using the pET20b(+) expression system as described before.[5] 
3. Nitroolefins 2a-f
Nitroolefins 2e and 2f were commercially available while 2a,[6] 2b,[7] 2c,[8] and 2d[9] were 
synthesized and purified according to literature procedures.
4. Catalytic activity assay with 4-OT in water/co-solvent solvent 
systems
Nitroolefins 2a-f are insufficiently soluble in water to reach practical concentrations 
(≥ 0.5 mM) in 100% aqueous solvent systems for analytical and preparative scale 4-OT-
catalyzed Michael-type addition reactions. Therefore, a co-solvent that enhances solubility 
of the nitroolefins to a practical level (≥ 0.5 mM) in aqueous solvent systems was required. 
Apart from enhancing solubility of 2a-f, the co-solvent should be water-miscible, should 
not impede catalytic activity of 4-OT, and should not chemically react with any of the 
substrates (1 and 2a-f). The following water-miscible solvents were tested for suitability: 
EtOH, DMSO, MeCN, THF, dioxane, and DMF. The experimental set up was as follows: 
the kobs of the 4-OT-catalyzed Michael-type addition of acetaldehyde 1 to t-nitrostyrene 
2g in the presence of 5% co-solvent (i.e. 20 mM NaH2PO4 buffer/co-solvent 95/5 v/v) was 
determined by UV-spectroscopy (initial decay of absorbance at λmax of 2g (320 nm) in 
time). A minimum amount of co-solvent of 5% was required to get 2g into solution and 
to keep the Michael-type addition product 3g in solution after formation. Next, identical 
experiments were performed but with increased amounts of co-solvent of 10, 15, 30, 50, 
and 72.5% respectively. The concentrations of 4-OT (32.5 µM, 2.5 mol% compared to 2g), 
1 (65 mM), and 2g (1.3 mM) and final volumes (0.3 mL) were identical in all experiments. 
This means that catalytic activities of 4-OT in the presence of different co-solvents could be 
compared with each other and that the influence of increasing volume percentages of the 





















The results are summarized in Table S1 and show that the presence of 5% (v/v) of co-
solvents EtOH, DMSO, MeCN, THF, dioxane, and DMF resulted in comparable values of 
kobs between 3.5×10‒2 s‒1 and 5.1×10‒2 s‒1 for the 4-OT-catalyzed Michael-type addition of 
1 to 2g in 20 mM NaH2PO4 buffer (pH 5.5). An increase of the co-solvents to 10% (v/v) 
did not result in significant changes in any of the kobs values (3.6-5.1×10‒2 s‒1). Increasing 
the amount of co-solvent to 15% (v/v) significantly reduced the catalytic activity of 4-OT 
in dioxane, THF, and MeCN while catalytic activity in EtOH, DMSO, and DMF was more 
or less preserved. Increasing the percentage of co-solvent to 30% (v/v) reduced activity of 
4-OT in dioxane, THF, and MeCN to practically zero while activities were roughly halved 
in EtOH and DMF. In 30% (v/v) DMSO, activity was retained. Increase of co-solvent to 
50% (v/v) showed a further decrease of catalytic activity in EtOH and DMF while activity 
in 50% (v/v) DMSO remained at the identical level as in 5% (v/v) DMSO. When the 
percentage of DMSO was increased to 72.5% (v/v), significant decrease in catalytic activity 
was observed. Based on these results, DMSO was nominated as a suitable co-solvent for 
the 4-OT-catalyzed Michael-type addition reactions of acetaldehyde and nitroolefins 2a-f. 
Summarizing, DMSO was nominated since it is water-miscible, increases the solubility of 
2a-f (vide infra) in aqueous solvent systems and does not impede the catalytic activity of 
4-OT in aqueous solvent systems when present up to 50% (v/v).
Tabl e  S 1 .  kobs for 4-OT-catalyzed Michael-type addition of 1 to 2g in 20 mM NaH2PO4 (pH 5.5) in the 
presence of various amounts (v/v) of co-solvents EtOH, DMSO, DMF, dioxane, THF, and MeCN. Identical 
initial concentrations of 1 (c = 65 mM), 2g (c = 1.3 mM), and 4-OT (c = 32.5 µM) were applied in all 
experiments. kobs = D[2g]initial/[4-OT]
solvent 5% (v/v) 10% (v/v) 15% (v/v) 30% (v/v) 50% (v/v) 72.5% (v/v)
kobs (1.0×10‒2 s‒1)
EtOH 5.1 5.1 4.4 1.5 0.2 -
DMSO 3.9 5.1 4.6 3.9 3.8 0.4
DMF 3.6 3.9 3.2 2.2 1.4 0.6
dioxane 3.7 3.6 0.6 0.0 0.0 -
THF 3.5 3.6 1.7 0.0 0.0 -













c = 1.3 mM
acetaldehyde (1)
c = 65 mM 3g
The solubility of nitroolefins 2a-f was tested in several water/co-solvent solvent systems 
which revealed that nitroolefin 2b is soluble to at least 2.0 mM in a water/10% EtOH 





















of co-solvent DMSO to be soluble to at least 2.0 mM in aqueous solvent systems. The 
applied percentages of EtOH and DMSO as co-solvents in analytical and preparative scale 
experiments are listed in Tables 1 (main text), S2, and S3.
Analytical scale control experiments ascertained that EtOH and DMSO solely act as co-
solvents in the 4-OT-catalyzed depletion of nitroolefins 2a-f and not as reagents (see main 
text for explanation and Section 5, Figures S1-S6).
5. Analytical scale 4-OT-catalyzed Michael-type addition reactions
General procedure for analytical scale reactions
The UV-spectroscopic assays to monitor the 4-OT-catalyzed Michael-type addition 
reactions were performed at 22°C by following the decrease in absorbance at λmax of the 
nitroolefin (2a-f) in course of time which corresponds to the depletion of the nitroolefin 
(see Table S2 for specific λmax values of 2a-f)
A stock solution of acetaldehyde (1) was prepared in 20 mM NaH2PO4 buffer (pH 5.5), 
while separate stock solutions of nitroolefins 2a-f were prepared in absolute ethanol or DMSO 
(see Table S2). The rationale behind applying ethanol and DMSO as co-solvents is explained 
in detail in Section 4. An aliquot of enzyme (4-OT) and acetaldehyde (1) were incubated 
in 20 mM NaH2PO4 buffer (pH 5.5) in a 1 mm cuvette, after which the assay was initiated 
by the addition of the nitroolefin (2a-f). The resulting final concentrations of nitroolefin, 
acetaldehyde, and enzyme were as indicated in Table S2. The final concentrations of nitroolefins 
were generally adjusted on basis of their specific εmax values (i.e. the lower the εmax value, the 
higher the final concentration: 1.9 < Absorbance at λmax < 2.9 except for 2a). The total volume 
of the reaction mixtures was 0.3 mL and the final ratios of water/EtOH or water/DMSO were 
as indicated in Table S2 for each specific nitroolefin. The reactions were monitored in course 
of time by recording absorbance spectra from 200 to 400, or 200-600 nm, and the spectra 
were analyzed using the software provided with the UV-VIS spectrophotometer (Jasco). The 
following control experiments were run for each nitroolefin; 1) conditions as in Table S2 but 
in the absence of 4-OT; 2) conditions as in Table S2 but in the absence of acetaldehyde 1; 3) 
Tabl e  S 2 .  Conditions of analytical scale, 4-OT-catalyzed Michael-type additions of acetaldehyde 1 to 






















1 2 a 378 13.5 DMSO 0.7 25 37 DMSO 40% 2.0
2 2 b 375 15.0 EtOH 1.3 50 70 EtOH 10% 0.5
3 2 c 249 8.2 DMSO 3.0 150 160 DMSO 5% 0.4
4 2 d 362 16.6 DMSO 1.7 50 160 DMSO 40% 0.3
5 2 e 320 19.2 DMSO 1.3 65 32 DMSO 45% 1.0





















conditions as in Table S2 but in the presence of 4-OT P1A instead of 4-OT wild-type. During 
all these control experiments no significant decreases of absorbances at λmax values of 2a-f 
(except for 2c, see main text) were observed (see Figures S1-S6). 
A control experiment with synthetic 4-OT was performed for the reaction of acetaldehyde 
(1) with nitroolefin 2a. Fully folded synthetic 4-OT was prepared as described elsewhere.[2] 
The folded synthetic 4-OT was incubated with 1 and 2a under the same conditions as those for 
the experiment with recombinant 4-OT (Table S2, entry 1). The reaction was monitored for 
the same period of time as for the experiment with recombinant 4-OT and a similar decrease 
of absorbance at 378 nm, corresponding to the disappearance of 2a, was observed (Figure S1).
UV-spectra, recorded after appropriate time intervals, to monitor the progress of analytical 
scale experiments and UV time course measurements of the control experiments, monitoring 
the change in absorbance at λmax of the respective nitroolefin, are visualized in Figures S1-S6.
Time (min)


























t = 0 min t = 60 min t = 120 min
Without acetaldehyde
Time (min)
























t = 0 min t = 10 min t = 30 min
Fi g u re  S 1 .  UV-spectra (left) showing the depletion of nitroolefin 2a incubated with 1 and recombinant 
4-OT in 20 mM NaH2PO4 buffer/40% DMSO (v/v) at pH 5.5; UV-spectra (right) following the depletion of 
2a at 378 nm in the presence of 1 and 4-OT P1A (□), recombinant 4-OT (▲), synthetic 4-OT (◊), in the 
















































t = 0 min t = 60 min t = 120 min
Without acetaldehyde
Time (min)
























t = 0 min t = 10 min t = 30 min
Fi g u re  S 2 .  UV-spectra (left) showing the depletion of nitroolefin 2b incubated with 1 and recombinant 
4-OT in 20 mM NaH2PO4 buffer/10% EtOH (v/v) at pH 5.5; UV-spectra (right) following the depletion of 2b 
at 375 nm in the presence of 1 and 4-OT P1A (□), recombinant 4-OT (▲), in the presence of 4-OT but the 
absence of 1 (●), and without 4-OT (Blank, ○). 
Time (min)


























t = 2 min t = 6 min t = 20 min
Without acetaldehyde
Time (min)





























t = 0 min t = 4 min t = 10 min
Fi g u re  S 3 .  UV-spectra (left) showing the depletion of nitroolefin 2c incubated with 1 and recombinant 
4-OT in 20 mM NaH2PO4buffer/5% DMSO (v/v) at pH 5.5; UV-spectra (right) following the depletion of 2c 
at 249 nm in the presence of 1 and 4-OT P1A (□), recombinant 4-OT (▲), in the presence of 4-OT but the 
















































t = 2 min t = 6 min t = 20 min
Without acetaldehyde
Time (min)





























t = 0 min t = 4 min t = 10 min
Fi g u re  S 4 .  UV-spectra (left) showing the depletion of nitroolefin 2d incubated with 1 and recombinant 
4-OT in 20 mM NaH2PO4buffer/40% DMSO (v/v) at pH 5.5; UV-spectra (right) following the depletion of 
2d at 362 nm in the presence of 1 and 4-OT P1A (□), recombinant 4-OT (▲), in the presence of 4-OT but 
the absence of 1 (●), and without 4-OT (Blank, ○).
Time (min)
























































t = 0 min t = 15 min t = 50 min
Fi g u re  S 5 .  UV-spectra (left) showing the depletion of nitroolefin 2e incubated with 1 and recombinant 
4-OT in 20 mM NaH2PO4buffer/45% DMSO (v/v) at pH 5.5; UV-spectra (right) following the depletion of 
2e at 320 nm in the presence of 1 and 4-OT P1A (□), recombinant 4-OT (▲), in the presence of 4-OT but 





















Fi g u re  S 6 .  UV-spectra (left) showing the depletion of nitroolefin 2f incubated with 1 and recombinant 
4-OT in 20 mM NaH2PO4buffer/40% DMSO (v/v) at pH 5.5; UV-spectra (right) following the depletion of 
2f at 324 nm in the presence of 1 and 4-OT P1A (□), recombinant 4-OT (▲), in the presence of 4-OT but the 
absence of 1 (●), and without 4-OT (Blank, ○).
Time (min)
























































t = 0 min t = 15 min t = 50 min
6. Preparative scale reactions, characterization, and enantiomeric 
excess determination of 3a-f
The conditions of preparative scale, 4-OT-catalyzed Michael-type additions of acetaldehyde 1 
to nitroolefins 2a-f are summarized in Table S3. Specific details can be found in the procedures 
following Table S3. The rationale behind applying ethanol and DMSO as co-solvents is explained 
in detail in Section 4. After work-up procedures, products 3a,c-f were characterized by recording 
1H NMR spectra and comparison with data in the literature (see specific procedures following 
Table S3 for references). Product 3b has been characterized by 1H NMR, 13C NMR, and exact 
mass spectroscopy since, to the best of our knowledge, 3b has not been described in the literature. 
The enantiomeric excess of 3c was determined by GC with a chiral stationary phase (HP chiral 
20% Permethylated beta-cyclodextrin column). Enantiomeric excesses of products 3a,b,d-f 
were determined by reverse or normal phase HPLC with a chiral stationary phase. The aldehyde 
functionality of 3a was derivatized into a methyl ester according to a literature procedure to be 
able to determine the enantiomeric excess.[10] The aldehyde functionality of 3b was derivatized 
into a cyclic acetal to be able to determine the enantiomeric excess (see Section 8 for details). 
As control experiments, blank reactions of acetaldehyde and nitroolefin without enzyme were 
performed under the exact same conditions as described in Table S3. No formation of products 
3a-f was observed in any of these control experiments. During the control experiment with 
2c, formation of side product 4-methyl-1-nitropentane-2-ol was observed as a result of non-
enzymatic water addition to 2c. Analysis of this side product, and of chemically obtained 
4-methyl-1-nitropentane-2-ol, with GC with a chiral stationary phase indeed revealed that side 
product 4-methyl-1-nitropentane-2-ol was obtained racemic (HP chiral 20% Permethylated 





















3-(3-(cyclopentyloxy)-4-methoxyphenyl)-4-nitrobutanal (3 a )
Tabl e  S 3 .  Conditions of preparative scale, 4-OT-catalyzed Michael-type additions of acetaldehyde 1 to 




















1 2 a 60 2.0 50 73.3 3.7 DMSO 40% 2.5 3 a
2 2 b 60 2.0 50 36.7 1.8 EtOH 10% 2.0 3 b
3 2 c 12.8 3.0 150 160 5.3 DMSO 5% 0.4 3 c
4 2 d 25 5.0 50 150 3.0 DMSO 40% 2.0 3 d
5 2 e 50 1.3 65 36 2.8 DMSO 45% 2.5 3 e
6 2 f 60 2.0 50 30 1.5 DMSO 40% 2.5 3 f
A solution of nitroolefin 2a (31.6 mg, 0.12 mmol) in DMSO (6.0 mL) was added to a mixture 
of acetaldehyde 1 (132 mg, 3.0 mmol) and 4-OT (30 mg, 4.4×10‒3 mmol, 3.7 mol%) in 20 mM 
NaH2PO4 buffer pH 5.5 and DMSO (final volume mixture: 60.0 mL. Final ratio water/DMSO: 
60/40 v/v). The mixture was incubated at 22°C and reaction progress was monitored by 
recording UV-spectra of aliquots taken from the reaction mixture after regular time intervals. 
After 2.5 h, all 2a was converted and the reaction mixture was divided over six polypropylene 
tubes (15 mL, CELLSTAR). The solvents were evaporated using an acid-resistant CentriVap 
vacuum concentrator (55°C, overnight). Water (3 mL) and chloroform (3 mL) were added 
to each tube. The dry residues were dissolved/suspended by vigorous stirring (additional 
scraping with a spatula may be required). The combined water and chloroform layers were 
separated in a separatory funnel. The water layer was extracted with chloroform (3×10 mL). 
The combined organic layers were dried with MgSO4 and concentrated in vacuo to yield 3a 
(23.6 mg, 7.7×10‒2 mmol, 64%) as a colorless oil. The 1H NMR spectroscopic data of 3a are 
in agreement with published data.[11] Enantiomeric excess was determined by normal phase 
HPLC with derivatized 3a using a Chiralpak IB column (n-heptane/i-PrOH 95:5, 25°C) at 1 





















3-(3-hydroxy-4-methoxyphenyl)-4-nitrobutanal (3 b ) 
A solution of nitroolefin 2b (23.4 mg, 0.12 mmol) in ethanol (6.0 mL) was added to a 
mixture of acetaldehyde 1 (132 mg, 3.0 mmol) and 4-OT (15 mg, 2.2×10‒3 mmol, 1.8 mol%) 
in 20 mM NaH2PO4 buffer pH 5.5 (final volume mixture: 60.0 mL). The reaction mixture 
was incubated at 22°C and reaction progress was monitored by recording UV-spectra of 
aliquots taken from the reaction mixture after regular time intervals. After 2 h, all 2b was 
converted and the reaction mixture was centrifuged using a Vivaspin column (Sartorius 
Stedim Biotech S.A., France) with a 5000 Da molecular weight cut-off filter to remove 4-OT. 
The flow-through was collected and extracted with ethyl acetate (3×25 mL). The combined 
organic layers were dried with brine (25 mL) and MgSO4 and concentrated in vacuo to yield 
3b (14.1 mg, 5.9×10‒2 mmol, 49%) as a colorless oil. 1H NMR (300 MHz, CDCl3, 25°C) δ 
9.69 (t, J = 1.2 Hz, 1H), 6.80 (d, J = 8.2 Hz, 1H), 6.78 (d, J = 2.3 Hz, 1H), 6.72 (dd, J = 8.2, 
2.3 Hz, 1H), 5.63 (b, 1H), 4.62 (dd, J = 12.4, 7.2 Hz, 1H), 4.56 (dd, J = 12.4, 7.6 Hz, 1H), 3.98 
(dddd, J = 7.6, 7.6, 7.2, 6.8 Hz, 1H), 3.87 (s, 3H), 2.91 (ddd, J = 18.0, 7.6, 1.2 Hz, 1H), 2.87 
(ddd, J = 18.0, 6.8, 1.2 Hz, 1H); 13C NMR (125 MHz, CDCl3, 25°C) δ 199.02, 146.26, 146.06, 
131.09, 119.26, 113.14, 111.00, 79.58, 55.91, 46.38, 37.54; HRMS (ESI): m/z = 240.08655 
[M+H]+ (calcd. 240.08665 for C11H14NO5); Enantiomeric excess was determined by reverse 
phase HPLC with derivatized 3b using a Chiracel AD-RH column (MeCN/water 40:60, 
25°C) at 0.8 mL/min, UV detection at 220 nm: tR: (minor) = 19.9 min, (major) = 29.3 min.
5-methyl-3-(nitromethyl)hexanal (3 c )
A solution of nitroolefin 2c (5.0 mg, 3.9×10‒2 mmol) in DMSO (0.64 mL) was added to a mixture 
of acetaldehyde 1 (85.3 mg, 1.94 mmol) and 4-OT (14.1 mg, 2.07×10‒3 mmol, 5.3 mol%) in 20 
mM NaH2PO4 buffer pH 5.5 (final volume mixture: 12.8 mL). The mixture was left at 22°C and 
after 25 min the mixture was extracted with toluene (3×10 mL). The combined organic layers 
were dried (Na2SO4) and concentrated in vacuo to yield 3c (5.0 mg, 2.9×10−2 mmol, 74%) as a 
colorless oil. The 1H NMR spectroscopic data of 3c are in agreement with published data.[12] 
Enantiomeric excess was determined by GC (HP chiral 20% Permethylated beta-cyclodextrin 





















(E)-3-(nitromethyl)-5-phenylpent-4-enal (3 d )
A solution of nitroolefin 2d (21.9 mg, 1.25×10‒1 mmol) in DMSO (10 mL) was added to 
a mixture of acetaldehyde 1 (55.1 mg, 1.25 mmol) and 4-OT (25.5 mg, 3.74×10‒3 mmol, 
3.0 mol%) in 20 mM NaH2PO4 buffer pH 5.5 (final volume mixture: 25.0 mL. Final ratio 
water/DMSO: 60/40 v/v). The mixture was left at 22°C and reaction progress was monitored 
by recording UV-spectra of aliquots taken from the reaction mixture after regular time 
intervals. After 2.0 h, all 2d was converted and the reaction mixture was divided over six 
polypropylene tubes (15 mL, CELLSTAR). The solvents were evaporated using an acid-
resistant CentriVap vacuum concentrator (55°C, overnight). Water (3 mL) and chloroform 
(3 mL) were added to each tube. The dry residues were dissolved/suspended by vigorous 
stirring (additional scraping with a spatula may be required). The combined water and 
chloroform layers were separated in a separatory funnel. The water layer was extracted 
with chloroform (3×10 mL). The combined organic layers were dried with MgSO4 and 
concentrated in vacuo to yield 3d (17.6 mg, 8.0×10‒2 mmol, 64%), and slight amounts of 
impurities (~10% compared to 3d), as a yellowish oil. The 1H NMR spectroscopic data of 
3d are in agreement with published data.[13] Enantiomeric excess was determined by reverse 
phase HPLC using a Chiracel AD-RH column (MeCN/water 40:60, 25°C) at 0.8 mL/min, 
UV detection at 210 nm: tR: (minor) = 6.9 min, (major) = 7.4 min.
3-(4-chlorophenyl)-4-nitrobutanal (3 e )
A solution of nitroolefin 2e (12.0 mg, 6.5×10‒2 mmol) in DMSO (2.5 mL) was added to a 
mixture of 4-OT (12.5 mg, 1.8×10‒3 mmol, 2.8 mol%) in 20 mM NaH2PO4 buffer pH 5.5 and 
DMSO. Acetaldehyde 1 (143 mg, 3.25 mmol) was added and the mixture was left at 22°C 
(final volume mixture: 50.0 mL. Final ratio water/DMSO: 55/45 v/v). Reaction progress was 
monitored by recording UV-spectra of aliquots taken from the reaction mixture after regular 
time intervals. After 2.5 h, all 2e was converted and the reaction mixture was divided over 
six polypropylene tubes (15 mL, CELLSTAR). The solvents were evaporated using an acid-
resistant CentriVap vacuum concentrator (55°C, overnight). Water (3 mL) and chloroform (3 
mL) were added to each tube. The dry residues were dissolved/suspended by vigorous stirring 





















layers were separated in a separatory funnel. The water layer was extracted with chloroform 
(3×10 mL). The combined organic layers were dried with MgSO4 and concentrated in vacuo 
to yield 3e (7.5 mg, 3.3×10‒2 mmol, 51%) as a colorless oil. The 1H NMR spectroscopic data of 
3e are in agreement with published data.[12,14] Enantiomeric excess was determined by reverse 
phase HPLC using a Chiracel AD-RH column (MeCN/water 32:68, 22°C) at 0.5 mL/min, 
UV detection at 220 nm: tR: (minor) = 37.3 min, (major) = 40.0 min. 
3-(4-fluorophenyl)-4-nitrobutanal (3 f )
A solution of nitroolefin 2f (20.1 mg, 0.12 mmol) in DMSO (6.0 mL) was added to a mixture 
of acetaldehyde 1 (132 mg, 3.0 mmol) and 4-OT (12.0 mg, 1.8×10‒3 mmol, 1.5 mol%) in 20 
mM NaH2PO4 buffer pH 5.5 and DMSO. The mixture was left at 22°C (final volume mixture: 
60.0 mL. Final ratio water/DMSO: 60/40 v/v). Reaction progress was monitored by recording 
UV-spectra of aliquots taken from the reaction mixture after regular time intervals. After 
2.5 h, all 2f was converted and the reaction mixture was divided over six polypropylene 
tubes (15 mL, CELLSTAR). The solvents were evaporated using an acid-resistant CentriVap 
vacuum concentrator (55°C, overnight). Water (3 mL) and chloroform (3 mL) were added 
to each tube. The dry residues were dissolved/suspended by vigorous stirring (additional 
scraping with a spatula may be required). The combined water and chloroform layers were 
separated in a separatory funnel. The water layer was extracted with chloroform (3×10 mL). 
The combined organic layers were dried with Na2SO4 and concentrated in vacuo to yield 
3f (6.7 mg, 3.2×10‒2 mmol, 26%) as a colorless oil. The 1H NMR spectroscopic data of 3f 
are in agreement with published data.[14] Enantiomeric excess was determined by reverse 
phase HPLC using a Chiracel AD-RH column (MeCN/water 30:70, 25°C) at 0.5 mL/min, 
UV detection at 210 nm: tR: (minor) = 34.1 min, (major) = 35.9 min.
7. Synthesis of racemic 3a-f for enantiomeric excess determinations
General procedure: racemic 3a-f were synthesized to serve as references for enantiomeric 
excess determinations of enzymatically obtained 3a-f. Racemic 3a-f were synthesized with 
the following general procedure: under a nitrogen atmosphere, nitroolefin, piperidine (0.2 
eq) and acetaldehyde (10 eq) were dissolved in THF or MeOH (3 mL). The solution was 
stirred at room temperature for 48 h. The reaction progress was monitored by thin layer 
chromatography (TLC, silica, n-heptane/EtOAc, visualization: KMnO4). The solvent was 
evaporated and the residue purified by column chromatography (silica gel, n-heptane/
AcOEt). The 1H NMR spectroscopic data of 3a,c-f were in agreement with published data: 





















3-(3-(cyclopentyloxy)-4-methoxyphenyl)-4-nitrobutanal (3a) Nitroolefin 2a (213 mg, 
0.81 mmol) gave 3a (17 mg, 5.5×10‒2 mmol, 7%) after column chromatography (silica gel, 
n-heptane/AcOEt 4/1). Reaction solvent: MeOH.
3-(3-hydroxy-4-methoxyphenyl)-4-nitrobutanal (3b) Nitroolefin 2b (158 mg, 0.81 mmol) 
gave 3b (28 mg, 0.12 mmol, 14%) after column chromatography (silica gel, n-heptane/
AcOEt 2/1). Reaction solvent: MeOH. 1H NMR spectroscopic data are in agreement with 
the data from enzymatically obtained 3b.
5-methyl-3-(nitromethyl)hexanal (3c) Nitroolefin 2c (100 mg, 0.77 mmol) gave 3c (20 mg, 
0.12 mmol, 15%) after column chromatography (silica gel, n-heptane/AcOEt 4/1). Reaction 
solvent: THF.
(E)-3-(nitromethyl)-5-phenylpent-4-enal (3d) Note: reaction time was 240 h. Nitroolefin 
2d (100 mg, 0.57 mmol) gave 3d (2.4 mg, 1.1×10‒2 mmol, 2%) after column chromatography 
(silica gel, n-heptane/AcOEt 95/5 → 50/50). Reaction solvent: MeOH.
3-(4-chlorophenyl)-4-nitrobutanal (3e) Nitroolefin 2e (183 mg, 1.00 mmol) gave 3e (41 
mg, 0.18 mmol, 18%) after column chromatography (silica gel, n-heptane/AcOEt 3/1). 
Reaction solvent: MeOH.
3-(4-fluorophenyl)-4-nitrobutanal (3f) Nitroolefin 2f (135 mg, 0.81 mmol) gave 3f (30 
mg, 0.14 mmol, 18%) after column chromatography (silica gel, n-heptane/AcOEt 4/1). 
Reaction solvent: MeOH.
8. Derivatization of 3a and 3b for enantiomeric excess determinations
Methyl 3-(3-(cyclopentyloxy)-4-methoxyphenyl)-4-nitrobutanoate (4 a )
The aldehyde functionalities of enzymatically obtained 3a and racemic 3a were converted 





















5-(1-(1,3-dioxolan-2-yl)-3-nitropropan-2-yl)-2-methoxyphenol (4 b ) 
Under a nitrogen atmosphere, enzymatically obtained 3b (12.5 mg, 5.2×10−2 mmol), 
ethylene glycol (64 mg, 1.0 mmol), and p-TsOH (5 mol%, 0.5 mg, 2.6×10−3 mmol) were 
stirred in chloroform (2 mL) for 4 d at room temperature. Reaction progress was monitored 
by thin layer chromatography (silica, hexanes/EtOAc 1/1, Rf product = 0.31, Rf starting 
material = 0.25; visualization KMnO4). The reaction mixture was concentrated and purified 
by column chromatography (silica gel, hexanes/EtOAc 2/1) to give 4b (5.0 mg, 1.8×10−2 
mmol, 34%) as a colorless oil. 1H NMR (300 MHz, CDCl3, 25°C) δ 6.79 (d, J = 2.2 Hz, 1H), 
6.78 (d, J = 8.4 Hz, 1H), 6.70 (dd, J = 8.4, 2.2 Hz, 1H), 5.61 (b, 1H), 4.74 (dd, J = 6.5, 3.1 Hz, 
1H), 4.70 (dd, J = 12.5, 6.5 Hz, 1H), 4.70 (dd, J = 12.5, 9.0 Hz, 1H), 3.99-3.93 (m, 2H), 3.87 
(s, 3H), 3.84-3.77 (m, 2H), 3.66 (dddd, J = 9.0, 8.0, 6.5, 6.5 Hz, 1H), 2.07 (ddd, J = 14.0, 8.0, 
3.1 Hz, 1H), 1.92 (ddd, J = 14.0, 6.5, 6.5 Hz, 1H); HRMS (ESI): m/z = 284.11249 [M+H]+ 
(calcd. 284.11286 for C13H18NO6)





















9. HPLC and GC chromatograms of enantiomeric excess determinations
Retention time (min)

































































































Fi g u re  S 7 .  HPLC chromatograms of racemic 4a and enzymatically obtained 4a.
Fi g u re  S 8 .  HPLC chromatograms of racemic 4b and enzymatically obtained 4b.
Retention time (min)
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Fi g u re  S 9 .  GC chromatograms of racemic 3c and enzymatically obtained 3c.











































































































































































Fi g u re  S 1 1 .  HPLC chromatograms of racemic 3e and enzymatically obtained 3e.


























































































































































Fi g u re  S 1 3 .  1H NMR spectrum of enzymatically obtained 3a.
Fi g u re  S 1 4 . 1H  N M R  sp e c tr u m  of  en z y m ati c a l l y  obt ai n e d  3 b.
























































































































Fi g u re  S 1 5 .  1H NMR spectrum of enzymatically obtained 3c.













































































Fi g u re  S 1 7 .  1H NMR spectrum of enzymatically obtained 3e.

































































































































































































































S c h em e  S 1 .  Proposed mechanism for the 4-OT-catalyzed Michael-type addition of acetaldehyde 1 to 
nitroolefins 2a-g yielding γ-nitroaldehydes 3a-g.
11. Proposed reaction mechanism of 4-OT-catalyzed Michael-type 
addition of acetaldehyde 1 to nitroolefins 2a-g
12. Absolute configuration determination of major enantiomers of 
enzymatically obtained 3a-g
The absolute configurations of the major enantiomers of enzymatically obtained 3a-g, 
respectively, were determined by HPLC with a chiral stationary phase and/or by optical rotation 
(Table S4). As described in detail in Section 9, the enantiomeric excesses of enzymatically 
obtained 3a-g were determined by HPLC or GC with a chiral stationary phase. The absolute 
configurations of the major enantiomers of products 3a and 3g, respectively, were both assigned 
to be (S) unambiguously by comparison with HPLC data in the literature (Table S4).
Optical rotations of enzymatically obtained 3a-g were measured to elucidate the absolute 
configurations of the major enantiomers of 3b-f, respectively. In all cases a negative rotation 
was found (Table S4). Comparison with literature data revealed that the chiral centers of 





















S1. This means that major enantiomers of 3a,d-g have the (S)-configuration while the 
major enantiomer of 3c has the (R)-configuration. The optical rotation experiments thus 
confirmed the (S)-configuration of 3a and 3g already established with chiral HPLC. The 
deviant configuration of 3c is due to different prioritization of the R side chain as compared 
to 3a,b,d-g. The negative rotation of 3b could not be compared with literature data since, to 
the best of our knowledge, 3b has not been reported in the literature so far. Since 3b gave a 
negative rotation, like 3a,c-g did, we assume an identical geometry of the chiral center of 3b 
(Scheme S1) as compared to the geometry of the chiral centers of 3a,c-g.
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Tabl e  S 4 .  Absolute configuration determination of major enantiomers of enzymatically obtained 3a-g, 
respectively, with HPLC and/or optical rotation. Literature references used for comparison of data to assign 





Absolute configuration of 
major enantiomer
(HPLC) Optical rotation ([a]25D)
Absolute configuration of 
major enantiomer
(optical rotation)
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[a] n.d. = not determined (i.e. absolute configuration was not determined by chiral HPLC).
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